Evaluation of anti-hyperlipidemic activity of Lekhana Basti in albino rats
S Auti Swapnil1, B Thakar Anup2, VJ Shukla3, BK Ashok4, B Ravishankar5
1 Ph. D. Scholar, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India 2 Associate Professor, Department of Panchakarma, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India 3 Head, Pharmaceutical Chemistry Laboratory, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India 4 Drug Discovery Laboratory, Himalaya Health Care, Makali, Bangalore, India 5 Director, Research and Development Unit, SDM Centre for Research in Ayurveda and Allied Sciences, Kuthpady, Udupi, Karnataka, India
Correspondence Address:
S Auti Swapnil B/16, Staff colony, Gujarat Ayurved University, Jamnagar, Gujarat India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-8520.119687
|
Lekhana Basti (medicated enema) is a Tikshna formulation which is basically aimed for Apatarpana of the body. The present study (medicated enema) was undertaken to evaluate its anti-hyperlipidemic activity in diet-induced hyperlipidemia animals. Parameters like changes in body weight, organ weight, serum total cholesterol, serum triglyceride, serum HDL cholesterol, and serum (LDL + VLDL) cholesterol were studied to assess the effect of therapy in comparison to the control groups. Lekhana Basti was found to be ineffective in producing anti-hyperlipidemic action potently, but still found to have cytoprotective activity against hyperlipidemia induced organ damage, which was also confirmed by attenuation of cell infiltration and microfatty changes on histopathological examination. |